Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Condition:   Non-small Cell Lung CancerInterventions:   Drug: imetelstat;   Drug: BevacizumabSponsor:   Geron CorporationRecruiting - verified August 2010